1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Pharma ADMET Testing Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Pharma ADMET Testing Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increased demand for drug development
- 5.1.2 Growth in pharmaceutical R&D investments
- 5.1.3 Focus on reducing drug failure rates
5.2 Market Opportunities
- 5.2.1 Adoption of AI in drug testing
- 5.2.2 Growth in biologics and biosimilars testing
- 5.2.3 Increasing outsourcing of ADMET testing
5.3 Future Trends
- 5.3.1 Shift toward personalized medicine testing
- 5.3.2 Development of high-throughput screening methods
- 5.3.3 Focus on predictive toxicology
5.4 Impact of Drivers and Restraints
6. Europe Pharma ADMET Testing Market Regional Analysis
6.1 Europe Pharma ADMET Testing Market Overview
6.2 Europe Pharma ADMET Testing Market Revenue 2020-2028 (US$ Million)
6.3 Europe Pharma ADMET Testing Market Forecast Analysis
7. Europe Pharma ADMET Testing Market Analysis – by Testing Type
7.1 In Vivo ADMET Testing
- 7.1.1 Overview
- 7.1.2 In Vivo ADMET Testing: Europe Pharma ADMET Testing Market – Revenue and Forecast to 2031 (US$ Million)
7.2 In Vitro ADMET Testing
- 7.2.1 Overview
- 7.2.2 In Vitro ADMET Testing: Europe Pharma ADMET Testing Market – Revenue and Forecast to 2031 (US$ Million)
7.3 In Silico ADMET Testing
- 7.3.1 Overview
- 7.3.2 In Silico ADMET Testing: Europe Pharma ADMET Testing Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Pharma ADMET Testing Market Analysis – by Technology
8.1 Cell Culture
- 8.1.1 Overview
- 8.1.2 Cell Culture: Europe Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
8.2 High Throughput
- 8.2.1 Overview
- 8.2.2 High Throughput: Europe Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Molecular Imaging
- 8.3.1 Overview
- 8.3.2 Molecular Imaging: Europe Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 OMICS Technology
- 8.4.1 Overview
- 8.4.2 OMICS Technology: Europe Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Pharma ADMET Testing Market Analysis – by Application
9.1 Systemic Toxicity
- 9.1.1 Overview
- 9.1.2 OMICS Technology: Europe Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Renal Toxicity
- 9.2.1 Overview
- 9.2.2 OMICS Technology: Europe Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Hepatotoxicity
- 9.3.1 Overview
- 9.3.2 OMICS Technology: Europe Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Neurotoxicity
- 9.4.1 Overview
- 9.4.2 OMICS Technology: Europe Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Pharma ADMET Testing Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Pharma ADMET Testing Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.1.1.1 Europe Pharma ADMET Testing Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 UK: Europe Pharma ADMET Testing Market Breakdown, by Testing Type
- 10.1.1.1.2 UK: Europe Pharma ADMET Testing Market Breakdown, by Technology
- 10.1.1.1.3 UK: Europe Pharma ADMET Testing Market Breakdown, by Application
- 10.1.1.2 Germany:
Europe Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Germany: Europe Pharma ADMET Testing Market Breakdown, by Testing Type
- 10.1.1.2.2 Germany: Europe Pharma ADMET Testing Market Breakdown, by Technology
- 10.1.1.2.3 Germany: Europe Pharma ADMET Testing Market Breakdown, by Application
- 10.1.1.3 France:
Europe Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 France: Europe Pharma ADMET Testing Market Breakdown, by Testing Type
- 10.1.1.3.2 France: Europe Pharma ADMET Testing Market Breakdown, by Technology
- 10.1.1.3.3 France: Europe Pharma ADMET Testing Market Breakdown, by Application
- 10.1.1.4 Russia:
Europe Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Russia: Europe Pharma ADMET Testing Market Breakdown, by Testing Type
- 10.1.1.4.2 Russia: Europe Pharma ADMET Testing Market Breakdown, by Technology
- 10.1.1.4.3 Russia: Europe Pharma ADMET Testing Market Breakdown, by Application
- 10.1.1.5 Italy:
Europe Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.1 Italy: Europe Pharma ADMET Testing Market Breakdown, by Testing Type
- 10.1.1.5.2 Italy: Europe Pharma ADMET Testing Market Breakdown, by Technology
- 10.1.1.5.3 Italy: Europe Pharma ADMET Testing Market Breakdown, by Application
- 10.1.1.6 Rest of Europe:
Europe Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Pharma ADMET Testing Market Breakdown, by Testing Type
- 10.1.1.6.2 Rest of Europe: Europe Pharma ADMET Testing Market Breakdown, by Technology
- 10.1.1.6.3 Rest of Europe: Europe Pharma ADMET Testing Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Pharma ADMET Testing Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Agilent Technologies, Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Bio-Rad Laboratories, Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Biovia (Dassault Systèmes)
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Charles River Laboratories
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 CMIC HOLDINGS Co., LTD
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Cyprotex Limited
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 IQVIA Inc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 MERCK KGaA
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Promega Corporation
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Wuxi AppTec
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For Europe Pharma ADMET Testing Market
